Posts by Team VIVA!
It’s not goodbye, it’s see you later
Regulatory codes, compliance teams, acronyms and writing gut-wrenching patient case studies were probably the first and hardest things to get my head around when I jumped headfirst into the healthcare industry and life at VIVA! Communications almost four years ago. As a Brit coming Down Under from an in-house role in the sports industry, there…
Read MoreVIVA! appoints Julia Slater as GM
VIVA! Communications (VIVA!) has today announced the appointment of Julia Slater as General Manager (GM) of the award-winning, independent, Australian health + wellness communications agency and Asia Pacific hub lead for GLOBALHealthPR. Julia brings more than a decade of PR and communications experience to her new role, to support VIVA!’s recent, unparalleled local and international…
Read MoreWorld Cancer Day 2021: committing to a cancer-free future
Today (February 4, 2021) marks World Cancer Day (WCD), a global cancer awareness initiative led by the Union for International Cancer Control (UICC). This year’s WCD theme of ‘I Am and I Will’ urges the global community to pledge their commitment to positive action towards creating a cancer-free future. In 2018, an estimated 18 million…
Read MoreCOVID-19 vaccine update
The urgency posed by the COVID-19 pandemic has seen some of the world’s leading research teams working tirelessly to find a vaccine for the virus. Impressively, while most vaccines require years of research and testing, this has facilitated the development of multiple COVID-19 vaccines in a matter of months, with many trials still in progress.…
Read MoreAustralian healthcare industry supports outcomes of Federal Budget 2020-21
Industry leaders across pharmaceutical, med-tech, biotech, pharmacy and community health have been quick to praise the Government’s record four-year injection of $467 billion into health announced in last night’s 2020-2021 Budget. This includes $2.8 billion for Australia’s medicines industry – the first significant investment since May 2018 and a considerable win for Medicines Australia (MA) and…
Read More